2024 Review-Breakthroughs that Redefined the Pharma Landscape Kumar Jeetendra | January 15, 2025 The year 2024 has been momentous for the pharmaceutical sector, characterized by new inventions, changes in policies, and partnerships that are likely to transform the future of health care. From new treatment methods to cutting edge technological development, here’s a summary of the main events that have transformed the pharm industry this year. Broader Use …
2025 in focus: The convergence of Pharma, Labs and Analytics Kumar Jeetendra | February 7, 2025 The year 2025 brings with it a new era of opportunity in the pharmaceutical, laboratory, and analytical markets with the coming of new possibilities with the help of technologies and regulatory changes. This fresh perspective towards personalized medicine will enable collaboration opportunities like never before. Let’s examine how the amalgamation of these fields works to …
Jodi Barrientos on Leading Synthetic Biology’s Next Wave Kumar Jeetendra | October 6, 2025 Microbioz India recently hosted a podcast in which Jodi Barrientos, CEO of Ribbon Bio, very eloquently described her career path, her thoughts on the future of synthetic bio, and the change(s) she hopes to implement in our industry. Jodi Barrientos spent 17 years in the commercial sector, exceeding the expectations of some of the world’s …
Quality First: Strengthening Compliance in a Fast-evolving Pharma World Kumar Jeetendra | March 5, 2026 The velocity at which pharmaceutical innovations are occurring is unparalleled in history. In this context, quality and compliance have shifted from being mere supporting functions to becoming critical strategic elements. Be it cutting-edge biologics and bespoke medicines, the digitization of manufacturing, or the globalization of supply chains, the pharma sector is traversing an arena that …
Analytics to Action: The Evolution of Modern Pharmaceutical Science Kumar Jeetendra | June 2, 2026 The technology boom is changing the pharmaceutical industry in a way that we will look back on as historically significant. From digital intelligence to advanced target therapies, the industry is innovating rapidly and moving toward an era of data driven design. Data is still of utmost importance. Today, using data and analytics is strategically as …
2026 Watchlist: Top 10 CROs Driving Innovation in Drug Development Kumar Jeetendra | June 24, 2026 The role of AI in research promises to bring new drugs to market faster than ever before. Drug development is complex. As a result, many of the best contract research organizations (CROs) have stopped being simple vendors or service delivery partners. They have become partners in strategic innovation. The CRO Leaders to Watch in 2026: …
The Intelligent Laboratory Kumar Jeetendra | August 8, 2026 Robotics now serve as the foundation for smart laboratories. “The laboratory of the future won’t simply generate data—it will understand it, predict outcomes, and drive better scientific decisions.” Some functionalities provided by automated robotic workstations include: High-throughput screening Sample sorting Automated weighing Liquid dispensing Plate handling Sample storage Microbiology workflows Once a robotic laboratory is …
Quality Without Compromise Kumar Jeetendra | August 8, 2026 The pharmaceutical sector is transforming rapidly. Resulting from this transformation, analytical labs will likely need to provide results that are faster, more accurate, and more reproducible. Ranging from small molecules to biologics, cell therapies, gene therapies, and tailored medicines, modern pharmaceutical products require advanced analytical technologies and sophisticated methods that can detect even the smallest …
Lab 4.0: Building the Intelligent, Connected & Automated Laboratory Kumar Jeetendra | September 7, 2026 The modern laboratory is evolving. For many years, laboratories have purchased equipment and software, such as instruments and laboratory information management systems (LIMS) and electronic laboratory notebooks (ELNs), without effectively addressing fragmented systems and data housed in disparate systems. From Digital Transformation to Intelligent Laboratory Ecosystems Lab 4.0 is the next chapter. Lab 4.0 incorporates …
EasyMax 102i: Making Pharmaceutical R&D More Reliable Kumar Jeetendra | September 7, 2026 Pharmaceutical research depends on reliable experiments. A small variation in temperature, stirring, dosing, or sampling can affect the final result—and may influence important decisions about process development and scale-up. The METTLER TOLEDO EasyMax 102i is designed to help scientists manage these variables more consistently. As an intuitive synthesis workstation, it brings together five essential experiment operations: temperature, stirring, …
